Goh Ohji1, Asako Doi2, Shungo Yamamoto1, Kentaro Iwata3. 1. Division of Infectious Diseases Therapeutics, Kobe University Graduate School of Medicine, Kusunokicho 7-5-2, Chuoku, Kobe, Hyogo 650-0017, Japan. 2. Division of Infectious Diseases, Kobe City Medical Center General Hospital, Kobe, Japan. 3. Division of Infectious Diseases Therapeutics, Kobe University Graduate School of Medicine, Kusunokicho 7-5-2, Chuoku, Kobe, Hyogo 650-0017, Japan. Electronic address: kentaroiwata1969@gmail.com.
Abstract
BACKGROUND: De-escalation therapy is a strategy used widely to treat infections while avoiding the use of broad-spectrum antimicrobials. However, there is a paucity of clinical evidence to demonstrate the effectiveness and safety of de-escalation therapy compared to conventional therapy. METHODS: A systematic review and meta-analysis was conducted on de-escalation therapy for a variety of infections. A search of the MEDLINE (via PubMed), EMBASE, and Cochrane Library databases up to July 2015 for relevant studies was performed. The primary outcome was relevant mortality, such as 30-day mortality and in-hospital mortality. A meta-analysis was to be conducted for the pooled odds ratio using the random-effects model when possible. Both randomized controlled trials and observational studies were included in the analysis. RESULTS: A total of 23 studies were included in the analysis. There was no difference in mortality for most infections, and some studies favored de-escalation over non-de-escalation for better survival. The quality of most studies included was not high. CONCLUSIONS: This review and analysis suggests that de-escalation therapy is safe and effective for most infections, although higher quality studies are needed in the future.
BACKGROUND: De-escalation therapy is a strategy used widely to treat infections while avoiding the use of broad-spectrum antimicrobials. However, there is a paucity of clinical evidence to demonstrate the effectiveness and safety of de-escalation therapy compared to conventional therapy. METHODS: A systematic review and meta-analysis was conducted on de-escalation therapy for a variety of infections. A search of the MEDLINE (via PubMed), EMBASE, and Cochrane Library databases up to July 2015 for relevant studies was performed. The primary outcome was relevant mortality, such as 30-day mortality and in-hospital mortality. A meta-analysis was to be conducted for the pooled odds ratio using the random-effects model when possible. Both randomized controlled trials and observational studies were included in the analysis. RESULTS: A total of 23 studies were included in the analysis. There was no difference in mortality for most infections, and some studies favored de-escalation over non-de-escalation for better survival. The quality of most studies included was not high. CONCLUSIONS: This review and analysis suggests that de-escalation therapy is safe and effective for most infections, although higher quality studies are needed in the future.
Authors: Hoe Nam Leong; Asok Kurup; Mak Yong Tan; Andrea Lay Hoon Kwa; Kui Hin Liau; Mark H Wilcox Journal: Infect Drug Resist Date: 2018-10-25 Impact factor: 4.003
Authors: Cristhieni Rodrigues; Rinaldo Focaccia Siciliano; Helio Caiaffa Filho; Cecília Eugenia Charbel; Luciane de Carvalho Sarahyba da Silva; Martina Baiardo Redaelli; Ana Paula de Paula Rosa Passetti; Maria Renata Gomes Franco; Flávia Rossi; Rogerio Zeigler; Daniel De Backer; Rafael Alves Franco; Juliano Pinheiro de Almeida; Stéphanie Itala Rizk; Julia Tizue Fukushima; Giovanni Landoni; David Everson Uip; Ludhmila Abrahão Hajjar; Tania Mara Varejão Strabelli Journal: J Intensive Care Date: 2019-07-22
Authors: Lindsey A Sellers; Kathryn M Fitton; Margaret F Segovia; Christy C Forehand; Kevin K Dobbin; Andrea Sikora Newsome Journal: SAGE Open Med Date: 2021-08-19